Creative Medical Technology Holdings, Inc. Repayments of Convertible Debt
Creative Medical Technology Holdings, Inc. (CELZ) reported Repayments of Convertible Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for the quarter ending 2022-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for the quarter ending 2021-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for the quarter ending 2021-09-30 was $506.50K.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for fiscal 2021 was $705.40K.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Creative Medical Technology Holdings, Inc. repayments of convertible debt for fiscal 2019 was $263.41K, a 35.01% decline from fiscal 2018.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 6 month as first filed | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $506.50K derived: sum of 2 quarters · filed 2023-03-31 | $705.40K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $506.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $705.40K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $198.91K 10-Q · filed 2022-08-12 | $341.65K 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | $69.30K derived: sum of 2 quarters · filed 2020-05-15 | $95.11K derived: sum of 3 quarters · filed 2020-05-15 | $95.11K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-12-31 | $69.30K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $95.11K derived: sum of 2 quarters · filed 2020-04-06 | $95.11K derived: sum of 3 quarters · filed 2020-04-06 | $263.41K 10-K · filed 2020-04-06 | |
| 2019-09-30 | $25.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $25.81K derived: sum of 2 quarters · filed 2019-11-14 | $194.11K 10-Q · filed 2019-11-14 | $194.11K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $168.30K 10-Q · filed 2019-08-13 | $168.30K derived: sum of 3 quarters · filed 2020-05-15 | $383.79K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-03-31 | $168.30K 10-Q · filed 2020-05-15 | $168.30K derived: sum of 2 quarters · filed 2020-05-15 | $383.79K derived: sum of 3 quarters · filed 2020-05-15 | $573.59K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $215.49K derived: sum of 2 quarters · filed 2020-04-06 | $405.29K derived: sum of 3 quarters · filed 2020-04-06 | $405.29K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $215.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $405.29K derived: sum of 2 quarters · filed 2019-11-14 | $405.29K 10-Q · filed 2019-11-14 | $405.29K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $189.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $189.80K 10-Q · filed 2019-08-13 | $189.80K derived: sum of 3 quarters · filed 2019-08-13 | $189.80K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-20 | $0.00 derived: sum of 2 quarters · filed 2019-05-20 | $0.00 derived: sum of 3 quarters · filed 2019-05-20 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $0.00 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |